Kenvue Inc. $KVUE Shares Sold by Security National Bank

Security National Bank lowered its stake in Kenvue Inc. (NYSE:KVUE) by 96.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,576 shares of the company’s stock after selling 39,057 shares during the quarter. Security National Bank’s holdings in Kenvue were worth $27,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Kenvue by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company’s stock valued at $4,052,913,000 after buying an additional 1,604,040 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Kenvue by 22.4% in the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after buying an additional 6,781,640 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Kenvue by 13.5% in the third quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company’s stock valued at $375,377,000 after buying an additional 2,747,952 shares in the last quarter. Van ECK Associates Corp grew its stake in shares of Kenvue by 101.3% in the third quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after buying an additional 9,240,434 shares in the last quarter. Finally, Amundi grew its stake in shares of Kenvue by 21.6% in the third quarter. Amundi now owns 17,645,761 shares of the company’s stock valued at $277,012,000 after buying an additional 3,135,871 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. UBS Group lowered their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Argus upgraded Kenvue to a “hold” rating in a research note on Friday, March 6th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and lowered their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Finally, Barclays lowered their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $19.33.

Kenvue Price Performance

Shares of NYSE KVUE opened at $17.09 on Monday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $24.35. The business has a 50 day moving average price of $17.48 and a two-hundred day moving average price of $17.33. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The firm has a market cap of $32.81 billion, a PE ratio of 20.10, a price-to-earnings-growth ratio of 1.30 and a beta of 0.55.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.24 EPS. Sell-side analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be given a $0.2075 dividend. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.59% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.